Similar articles

• Management of dyslipidemia for cardiovascular disease risk reduction: synopsis of the 2014 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guideline.

  Downs JR, O'Malley PG. Downs JR, et al. Ann Intern Med. 2015 Aug 18;163(4):291-7. doi: 10.7326/M15-0840. Ann Intern Med. 2015. PMID: 26099117
• Lipid Management Guidelines from the Departments of Veteran Affairs and Defense: A Critique.

  Bennet CS, Dahagam CR, Virani SS, Martin SS, Blumenthal RS, Michos ED, McEvoy JW. Bennet CS, et al. Am J Med. 2016 Sep;129(9):906-12. doi: 10.1016/j.amjmed.2016.04.012. Epub 2016 May 3. Am J Med. 2016. PMID: 27154781 Review.
• Summary for Patients: The Use of Opioids in the Management of Chronic Pain: Synopsis of the 2022 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.

  [No authors listed] [No authors listed] Ann Intern Med. 2023 Mar;176(3):I26. doi: 10.7326/P22-0030. Epub 2023 Feb 14. Ann Intern Med. 2023. PMID: 36780655 No abstract available.
• The Management of Substance Use Disorders: Synopsis of the 2021 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.

  Perry C, Liberto J, Milliken C, Burden J, Hagedorn H, Atkinson T, McKay JR, Mooney L, Sall J, Sasson C, Saxon A, Spevak C, Gordon AJ; VA/DoD Guideline Development Group. Perry C, et al. Ann Intern Med. 2022 May;175(5):720-731. doi: 10.7326/M21-4011. Epub 2022 Mar 22. Ann Intern Med. 2022. PMID: 35313113
• Management of Chronic Multisymptom Illness: Synopsis of the 2021 US Department of Veterans Affairs and US Department of Defense Clinical Practice Guideline.

  Robbins R, Helmer D, Monahan P, Hunt S, McAndrew L, Nazario M, Brown WJ, Chao W, Navarro A, Sall J. Robbins R, et al. Mayo Clin Proc. 2022 May;97(5):991-1002. doi: 10.1016/j.mayocp.2022.01.031. Epub 2022 Apr 9. Mayo Clin Proc. 2022. PMID: 35410746 Review.